Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Working Capital Changes (2016 - 2025)

Regenxbio (RGNX) has 12 years of Other Working Capital Changes data on record, last reported at $25.4 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 628.95% year-over-year to $25.4 million; the TTM value through Dec 2025 reached $29.3 million, up 88827.27%, while the annual FY2025 figure was $29.3 million, 88827.27% up from the prior year.
  • Other Working Capital Changes reached $25.4 million in Q4 2025 per RGNX's latest filing, up from $8.3 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $25.4 million in Q4 2025 and bottomed at -$14.2 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is $1.5 million, with a median of $390500.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: tumbled 1448.46% in 2022, then soared 1676.44% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$2.6 million in 2021, then skyrocketed by 241.47% to $3.7 million in 2022, then tumbled by 244.04% to -$5.3 million in 2023, then skyrocketed by 165.73% to $3.5 million in 2024, then surged by 628.95% to $25.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $25.4 million in Q4 2025, $8.3 million in Q3 2025, and -$6.4 million in Q2 2025.